I agree that this site is using cookies. You can find further informations here.
X
Vlachostergios, P.J
33  results:
Search for persons X
?
1

519P The efficacy of oxaliplatin desensitisation protocol i..:

Christodoulis, E. ; Vlachostergios, P.J. ; Connell, J....
Annals of Oncology.  35 (2024)  - p. S207 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Mutational profile of primary clear cell renal cell carcino..:

Vlachostergios, P. ; Papathanassiou, M. ; Anagnostou, M....
European Urology Open Science.  57 (2023)  - p. S253 , 2023
Link: https://doi.org/10.1016/..
 
?
3

Post-chemotherapy retroperitoneal lymph node dissection for..:

Evmorfopoulos, K.E. ; Vlachostergios, P. ; Chasiotis, G....
European Urology Open Science.  57 (2023)  - p. S14 , 2023
Link: https://doi.org/10.1016/..
 
?
4

Polycomb repressive complex 2 mutations predict survival be..:

Vlachostergios, P.J.
Immuno-Oncology and Technology.  10 (2021)  - p. 100035 , 2021
Link: https://doi.org/10.1016/..
 
?
5

Increased risk of venous thromboembolism (VTE) and shorter ..:

Jakubowski, C. ; Vlachostergios, P.J. ; Christos, P....
Thrombosis Research.  164 (2018)  - p. S214 , 2018
Link: https://doi.org/10.1016/..
 
?
6

GRP78 and α2-macroglobulin are new promising targets for me..:

Vlachostergios, P. J. ; Balmiki, R. L. ; Daya, R.
Clinical and Translational Oncology.  17 (2015)  11 - p. 932-934 , 2015
Link: https://doi.org/10.1007/..
 
?
7

Bevacizumab in advanced cervical cancer:

Vlachostergios, P. J. ; Papandreou, C. N.
Clinical and Translational Oncology.  16 (2014)  10 - p. 935-935 , 2014
Link: https://doi.org/10.1007/..
 
?
8

Erratum to: Bortezomib represses HIF-1α protein expression ..:

Befani, C. D. ; Vlachostergios, P. J. ; Hatzidaki, E....
Journal of Molecular Medicine.  91 (2013)  6 - p. 771-773 , 2013
Link: https://doi.org/10.1007/..
 
?
9

Predictive and prognostic value of LPS-stimulated cytokine ..:

Vlachostergios, P. J. ; Gioulbasanis, I. ; Ghosh, S....
Clinical and Translational Oncology.  15 (2013)  11 - p. 903-909 , 2013
Link: https://doi.org/10.1007/..
 
?
10

432 Endothelin-1 (ET-1) and nuclear factor-kappa B (NF-κB) ..:

Vlachostergios, P.J. ; Kakkas, G. ; Moutzouris, G....
European Urology Supplements.  11 (2012)  1 - p. e432-e432a , 2012
Link: https://doi.org/10.1016/..
 
?
11

Evaluation of a cytology-molecular co-test in urine of pati..:

Vlachostergios, P.J.V. ; Apostolopoulou, C. ; Mitrakas, L....
European Urology Open Science.  45 (2022)  - p. S226 , 2022
Link: https://doi.org/10.1016/..
 
?
12

Re-treatment with immune checkpoint inhibitors in renal cel..:

Vlachostergios, P.J.V. ; Papathanassiou, M. ; Tamposis, I....
European Urology Open Science.  45 (2022)  - p. S183 , 2022
Link: https://doi.org/10.1016/..
 
?
13

Genetic variants at 8q24 region are associated with prostat..:

Anagnostou, M.A. ; Vlachostergios, P.J.V. ; Papathanassiou, M....
European Urology Open Science.  45 (2022)  - p. S117 , 2022
Link: https://doi.org/10.1016/..
 
?
14

Designing a broad-spectrum integrative approach for cancer ..:

Block, K.I ; Gyllenhaal, C ; Lowe, L...
https://eprints.whiterose.ac.uk/110791/1/nihms754223.pdf.  , 2015
Link: https://eprints.whiteros..
 
?
15

Erratum to: Bortezomib represses HIF-1α protein expression ..:

Befani, C. D ; Vlachostergios, P. J ; Hatzidaki, E...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4713943/.  , 2013
Link: http://www.ncbi.nlm.nih...
 
1-15